Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
Mengmeng Li,
No information about this author
Jiangyi Wang,
No information about this author
Qingfeng Liu
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 10, 2025
Atopic
dermatitis
and
psoriasis
have
traditionally
been
considered
distinct
inflammatory
skin
diseases
with
unique
pathogenic
mechanisms.
However,
accumulating
evidence
suggests
significant
overlap
in
their
immunological
pathways,
metabolic
features,
microbiome
characteristics,
challenging
this
conventional
dichotomy.
This
review
comprehensively
examines
the
complex
relationship
between
atopic
dermatitis,
particular
emphasis
on
shared
We
analyze
networks,
microbial
factors
contributing
to
development
progression.
The
expands
upon
disease
spectrum
hypothesis
discusses
nomenclature
for
conditions
exhibiting
features
of
both
diseases.
critically
evaluate
clinical
histopathological
characteristics
concomitant
highlighting
recent
advances
molecular
diagnostics
accurate
differentiation.
Importantly,
we
propose
standardized
diagnostic
criteria
examine
current
therapeutic
strategies
managing
overlapping
conditions.
Recent
developments
targeted
therapies
implications
treatment
selection
are
thoroughly
discussed.
By
synthesizing
identifying
knowledge
gaps,
provides
insights
into
interplay
aiming
guide
decision-making
future
research
directions
evolving
field.
Language: Английский
Separable Microneedle Patch Integrated with the Dictamnine-Loaded Copper MOF Nanozyme for Atopic Dermatitis Treatment
ACS Applied Materials & Interfaces,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 24, 2025
Atopic
dermatitis
(AD)
is
a
chronic
inflammatory
skin
disorder
marked
by
thickening,
severe
pruritus,
lesions,
and
emotional
disturbances,
including
anxiety
depression-like
behavior.
Current
treatments
primarily
rely
on
localized
therapies,
which
can
lead
to
adverse
effects
such
as
hyperglycemia
Cushing's
syndrome
with
repeated
use.
To
address
these
issues,
we
developed
hyaluronic
acid-based
separable
microneedle
patch
(Dic@pCu-HA
MN),
integrating
polydopamine-coordinated
copper-based
metal-organic
frameworks
(pCu-MOFs)
the
anti-inflammatory
agent
dictamnine
(Dic),
for
synergistic
management
of
AD
its
neuropsychiatric
comorbidities.
pCu-MOFs
exhibited
dual
functionality
nanocargo
hydrophobic
Dic
(encapsulation
efficiency:
84.62
±
2.14%)
multienzyme
mimics
that
efficiently
scavenge
reactive
oxygen
species
(ROS)
(superoxide
radical
scavenging:
63.85
0.34%).
In
vitro
release
studies
demonstrated
ROS-responsive
86.80
4.83%
over
48
h
under
pathology-mimicking
conditions.
1-Chloro-2,4-dinitrochlorobenzene
(DNCB)-induced
mouse
model,
Dic@pCu-HA
MN
significantly
reduced
oxidative
stress
(8-OHdG:
85.1
7.0%
decrease),
suppressed
pro-inflammatory
cytokines
(IL-4:
70.0
7.8%
decrease
vs
control),
restored
barrier
integrity.
By
modulating
HPA
axis,
system
attenuated
neuroinflammation
alleviated
itching
(scratching
frequency:
40.1
41.3%
reduction)
behavior
(time
in
bright
box:
96.6
156.2%
increase).
This
combined
therapeutic
approach
not
only
offers
comprehensive
strategy
but
also
provides
potential
benefits
addressing
disorders
their
sequelae.
Language: Английский
Houttuynia cordata polysaccharides ameliorate atopic dermatitis in mice through modulation of skin immune barrier and lipid metabolism
Rong Huang,
No information about this author
Wenyu Zhang,
No information about this author
Yueqi Hu
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 144264 - 144264
Published: May 1, 2025
Language: Английский
Neutrophils in Atopic Dermatitis
Chih-Chao Chiang,
No information about this author
Wei-Jen Cheng,
No information about this author
Joseph Renz Marion Santiago Dela Cruz
No information about this author
et al.
Clinical Reviews in Allergy & Immunology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 18, 2024
Neutrophils
have
a
critical
role
in
inflammation.
Recent
studies
identified
their
distinctive
presence
certain
types
of
atopic
dermatitis
(AD),
yet
exact
function
remains
unclear.
This
review
aims
to
compile
elucidating
the
neutrophils
AD
pathophysiology.
Proteins
released
by
neutrophils,
including
myeloperoxidase,
elastase,
and
lipocalin,
contribute
pruritus
progression
AD.
Neutrophilic
oxidative
stress
formation
neutrophil
extracellular
traps
may
further
worsen
Elevated
elastase
high-mobility
group
box
1
protein
expression
patients'
skin
exacerbates
epidermal
barrier
defects.
Neutrophil-mast
cell
interactions
allergic
inflammation
steer
immunological
response
toward
Th2
imbalance
activate
Th17
pathway,
particularly
allergens
or
infections
linked
Notably,
drugs
alleviating
pruritic
symptoms
inhibit
neutrophilic
In
conclusion,
these
findings
underscore
that
be
therapeutic
targets
for
symptoms,
emphasizing
inclusion
treatment
strategies.
Language: Английский